BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25535966)

  • 1. No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis.
    Kienhöfer D; Hahn J; Schubert I; Reinwald C; Ipseiz N; Lang SC; Borràs ÈB; Amann K; Sjöwall C; Barron AE; Hueber AJ; Agerberth B; Schett G; Hoffmann MH
    PLoS One; 2014; 9(12):e115474. PubMed ID: 25535966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats.
    Hoffmann MH; Bruns H; Bäckdahl L; Neregård P; Niederreiter B; Herrmann M; Catrina AI; Agerberth B; Holmdahl R
    Ann Rheum Dis; 2013 Jul; 72(7):1239-48. PubMed ID: 23172753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cathelicidin LL-37-derived peptide IG-19 confers protection in a murine model of collagen-induced arthritis.
    Chow LN; Choi KY; Piyadasa H; Bossert M; Uzonna J; Klonisch T; Mookherjee N
    Mol Immunol; 2014 Feb; 57(2):86-92. PubMed ID: 24091294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.
    Leiss H; Niederreiter B; Bandur T; Schwarzecker B; Blüml S; Steiner G; Ulrich W; Smolen JS; Stummvoll GH
    Lupus; 2013 Jul; 22(8):778-92. PubMed ID: 23817510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients with Liver Diseases and Acts as a Protective Factor during Mouse Liver Injury.
    Wertenbruch S; Drescher H; Grossarth V; Kroy D; Giebeler A; Erschfeld S; Heinrichs D; Soehnlein O; Trautwein C; Brandenburg LO; Streetz K
    Digestion; 2015; 91(4):307-17. PubMed ID: 25998843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathelicidin (LL-37) and its correlation with pro-oxidant, antioxidant balance and disease activity in systemic lupus erythematosus: a cross-sectional human study.
    Sahebari M; Roshandel G; Saadati N; Saghafi M; Abdolahi N; Rezaieyazdi Z
    Lupus; 2017 Aug; 26(9):975-982. PubMed ID: 28420069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis.
    Gupta S; Winglee K; Gallo R; Bishai WR
    J Pathol; 2017 May; 242(1):52-61. PubMed ID: 28097645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation.
    Hemshekhar M; Piyadasa H; Mostafa D; Chow LNY; Halayko AJ; Mookherjee N
    Front Immunol; 2020; 11():1932. PubMed ID: 32973796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bioavailable form of curcumin suppresses cationic host defence peptides cathelicidin and calprotectin in a murine model of collagen-induced arthritis.
    Hemshekhar M; Lloyd D; El-Gabalawy H; Mookherjee N
    Arthritis Res Ther; 2023 Sep; 25(1):161. PubMed ID: 37667385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
    Shoda H; Fujio K; Shibuya M; Okamura T; Sumitomo S; Okamoto A; Sawada T; Yamamoto K
    Arthritis Res Ther; 2011; 13(6):R191. PubMed ID: 22108001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure.
    Zhou Q; Pan LL; Xue R; Ni G; Duan Y; Bai Y; Shi C; Ren Z; Wu C; Li G; Agerberth B; Sluijter JP; Sun J; Xiao J
    Theranostics; 2020; 10(14):6167-6181. PubMed ID: 32483446
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
    Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
    Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of the type I interferon receptor protects mice from experimental lupus.
    Nacionales DC; Kelly-Scumpia KM; Lee PY; Weinstein JS; Lyons R; Sobel E; Satoh M; Reeves WH
    Arthritis Rheum; 2007 Nov; 56(11):3770-83. PubMed ID: 17968932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease.
    Kahlenberg JM; Kaplan MJ
    J Immunol; 2013 Nov; 191(10):4895-901. PubMed ID: 24185823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.
    Cobo ER; Kissoon-Singh V; Moreau F; Holani R; Chadee K
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.
    Bei Y; Pan LL; Zhou Q; Zhao C; Xie Y; Wu C; Meng X; Gu H; Xu J; Zhou L; Sluijter JPG; Das S; Agerberth B; Sun J; Xiao J
    BMC Med; 2019 Feb; 17(1):42. PubMed ID: 30782145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus.
    Jing C; Zhang X; Song Z; Zheng Y; Yin Y
    J Interferon Cytokine Res; 2020 Jan; 40(1):33-42. PubMed ID: 31804874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
    Danka ES; Hunstad DA
    J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
    Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
    Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.